This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Procter & Gamble Reports Earnings Beat, but Analyst Sees Weakness

Shares of Procter & Gamble are climbing in Friday trading after the company reported earnings that came to 95 cents a share, topping analyst expectations.

General Motors Victims Fund Opens, Could Receive Hundreds of Claims

General Motors’ program to give relief to victims of its defective ignition switch is open to taking claims as of Friday.

Bed Bath & Beyond and 3D Systems Downgraded on Weak Sales

In Friday's Analysts' Actions, LinkedIn gets a price target increase while 3D Systems and Bed, Bath & Beyond get downgrades.

T-Mobile Likely to Reject Iliad's $15B Bid, Shares Should Benefit

French mobile phone company Iliad SA has offered $15 billion in cash, or $33 a share, for a controlling 56.6% stake in T-Mobile U.S., jumping in front of Sprint.

Real Money Previews

Kass: Avoid Most Social Media Stocks

A lot of things need to go well for the power of free to pay out all that it is promising.

Cramer: Russia's Impact Finally Being Felt

We're close to cutting numbers on major U.S. industrials now.

Sozzi: Mixed Signals From the Execs

An interview can provide a different perspective from an earnings call.

Mad Money Recap

'Mad Money' Lightning Round: Be Patient With Zynga

Cramer like Energy Transfer Partner's yield, would buy Kinder Morgan Energy Partners but thinks Pfizer is problematic.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Toxic Stocks You Should Sell Before the Next Drop

It's time to unload these toxic stocks from your portfolio.

5 M&A Deal Stocks to Watch for Premium Gains

Mergers and acquisitions can provide amazing value for purchasing firms' balance sheets -- and instant gratification for shareholders in the target firm.

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

5 Breakout Stocks Under $10 Set to Soar

These stocks under $10 look ready to break out and trade higher from current levels.

Must-See Charts: 5 Big Stocks to Buy for Tactical Gains

Here's a look at how some of the biggest names on Wall Street are trading technically right now.

MainStreet

Young Americans Prefer Bank Investments, Not Stock Market

That's a problem, because younger Americans aren't going to meet their giant retirement savings burden with low-yielding cash investments.

Here's How to Fill All Those Empty Jobs

All we hear are stories about all the people who can't find work. It might be a good idea to spend at least a little time talking about it.

Economy Is Up, But More Americans Have Big Debt

There are ominous signs that the economy, especially as it relates to consumer spending, may fall under the weight of too much household debt.

10 Most Affordable Cars Of 2014

A car that eats up more than half of a household's annual income isn't 'affordable.' One that gives you Bluetooth, USB ports and five years of fuel for $23,000 is.

What's Hot in Home Construction Now -- and Hopefully When You Sell

A survey shows not only what's important for builders to add, but also what homeowners who plan to renovate existing properties should include.

Biotech

Cel-Sci's Enrollment Math Doesn't Add up

In order to enroll the remaining 648 patients into the Multikine study by the end of 2015, Cel-Sci needs to average 40.5 patients per month, or 121.5 patients per quarter.

Biotech Stock Mailbag: Arrowhead, Catalyst Pharma

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Amarin Shocker: There's a Reason to be Bullish Right Now

If an FDA appeal decision goes in Amarin's favor, the stock is moving much higher.

Beyond Wall St.

Deal News

GoPro Wipes Out, LinkedIn Is Lights Out: Tech Winners & Losers

GoPro shares fell despite earnings beating consensus estimates, while Tesla and LinkedIn shares both jumped on strong results.

T-Mobile Receives Surprise $15 Billion Bid From Illiad

T-Mobile confirmed yesterday that is has received a $15 billion offer from French telecom company Illiad to acquire a majority stake in the wireless company.

Scientific Games Makes $5B Bet on Bally

Cash and debt deal would combine the two largest manufacturers of lottery and gambling equipment.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer: Whole Foods Share Price as Expensive as Its Food Prices

TheStreet's Jim Cramer says the stock price for Whole Foods might be as expensive as their food prices.

Herb Greenberg

Greenberg: Best Part About the Twitter Quarter

Twitter showed its willing to talk about its non-active users, the lurkers rather than the tweeters, and how to get everyone involved.

Stephanie Link

Oil Prices are Ridiculously Low Opportunity Still Abounds in E+P

Dan Dicker, Senior Energy contributor at Real Money, talks with Stephanie Link, co-portfolio manager at Action Alerts Plus about the current state of the oil market.

Chris Ciaccia

Tesla Earnings: What Wall Street's Saying

Tesla Motors continues to surprise investors on its way to producing 500,000 cars annually by 2020.

Adam Feuerstein

Cel-Sci's Enrollment Math Doesn't Add up

In order to enroll the remaining 648 patients into the Multikine study by the end of 2015, Cel-Sci needs to average 40.5 patients per month, or 121.5 patients per quarter.

Laurie Kulikowski

Whole Foods Earnings: What Wall Street Is Saying

Whole Foods shares slumped more than 5% after the specialty grocer again lowered its sales outlook as it faces intense competition. Here's what Wall Street is saying.

Dan Freed

$25 Billion Deal and JPMorgan Stumble to Aid of Bronx Homeowner

The mortgage settlement with JPMorgan and four other banks included very little cash and led one Bronx woman down a circuitous, two-year path before her loan could be modified.

Rocco Pendola

Further Proof Microsoft Is Doomed By Apple and Google's Dominance

Apple and Google have already crushed Microsoft with consumers. Expect a similar trend with business customers.

Ted Reed

Take a Look at ANA's New Boeing 787-9 Dreamliner, Set to Fly Monday

Boeing's first stretched 787 will fly Monday as an ANA charter flight from Tokyo Haneda. Air New Zealand plans the first revenue flight on August 9.

Leon Lazaroff

Scripps' Rich Boehne Wants Local TV Broadcasters to Wake Up to Digital

Scripps' merger with Journal Communications isn't only about carving out low-growth newspapers; it's about remaking local TV-broadcasters for the digital era.

Submit an article to us!
DOW 16,457.28 -106.02 -0.64%
S&P 500 1,919.55 -11.12 -0.58%
NASDAQ 4,332.7250 -37.0480 -0.85%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs